Your browser doesn't support javascript.
loading
Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.
Wong, Hui-Li; Lee, Belinda; Field, Kathryn; Lomax, Anna; Tacey, Mark; Shapiro, Jeremy; McKendrick, Joe; Zimet, Allan; Yip, Desmond; Nott, Louise; Jennens, Ross; Richardson, Gary; Tie, Jeanne; Kosmider, Suzanne; Parente, Phillip; Lim, Lionel; Cooray, Prasad; Tran, Ben; Desai, Jayesh; Wong, Rachel; Gibbs, Peter.
Afiliação
  • Wong HL; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia.
  • Lee B; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Scienc
  • Field K; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia.
  • Lomax A; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia.
  • Tacey M; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia; Department of Health Education and Research, Melbourne EpiCentre, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia.
  • Shapiro J; Cabrini Health, Department of Oncology, Malvern, Melbourne, Victoria, Australia; Department of Medicine, Nursing & Health Sciences, Monash University, Parkville, Melbourne, Victoria, Australia.
  • McKendrick J; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia.
  • Zimet A; Department of Oncology, Epworth Hospital, Richmond, Victoria, Australia.
  • Yip D; Department of Medical Oncology, Canberra and Calvary Hospitals, Garran, Australian Capital Territory, Australia.
  • Nott L; Department of Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia.
  • Jennens R; Department of Oncology, Epworth Hospital, Richmond, Victoria, Australia.
  • Richardson G; Cabrini Health, Department of Oncology, Malvern, Melbourne, Victoria, Australia.
  • Tie J; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia; Western Health, Department of Medical Oncology,
  • Kosmider S; Western Health, Department of Medical Oncology, Footscray, Melbourne, Victoria, Australia.
  • Parente P; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia.
  • Lim L; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia; Department of Oncology, Ringwood Private Hospital, Ringwood East, Victoria, Australia.
  • Cooray P; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia.
  • Tran B; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia.
  • Desai J; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia.
  • Wong R; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Eastern Health, Department of Medical Oncology, Melbourne, Victoria, Australia; Department of Medicine, Nursing & Health Sciences, Monash University,
  • Gibbs P; Systems Biology and Personalised Medicine Division, Walter & Eliza Hall Institute of Medical Research (WEHI), Parkville, Melbourne, Australia; Department of Medical Oncology, The Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia; Faculty of Medicine, Dentistry and Health Scienc
Clin Colorectal Cancer ; 15(2): e9-e15, 2016 Jun.
Article em En | MEDLINE | ID: mdl-26968236
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Colorectal Cancer Assunto da revista: GASTROENTEROLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália